Abiopharma

News list

Director Plump Andrew Stewart 🟢 acquired 212.5K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) Transaction Date: Apr 27, 2026 | Filing ID: 000136

Full text

News bot April 28, 2026, 10:11 a.m.
🔍 Plump Andrew Stewart (Director)

Company: TAKEDA PHARMACEUTICAL CO LTD (TAK)

Report Date: 2026-04-27
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 212,470
- Total shares held: 281,307
Detailed Transactions and Holdings:
- Acquired 212,470 shares of American Depositary Shares (Direct)
  Date: 2026-04-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 806,572.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of American Depositary Shares (Direct)
  Date: 2026-04-27 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 281,307.00
Footnotes:
- F1: On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.
- F2: Includes 464.432 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (329,478 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares).